FDA Recalls Launch Sequence Euphoria Capsules as Unapproved Drug
Launch Sequence Euphoria Capsules were marketed without FDA approval. Consumers should discontinue use immediately and contact the manufacturer.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall of an unapproved drug product. No illnesses, injuries, or hospitalizations have been reported. The recall addresses a regulatory violation—marketing a drug without FDA approval—rather than a documented safety hazard.
Plain-English summary
Launch Sequence Euphoria Capsules, 10-count tins, are being recalled because they were marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) from the FDA. The product's label claims indicate it is a drug, but no FDA approval was obtained prior to distribution.
The recalled product was distributed nationwide in the USA and Canada. The affected lot number is C07172101, with an expiration date of July 2024. Consumers who have purchased the product should discontinue use immediately.
For additional information or to report adverse effects, consumers may contact the manufacturer, Loud Muscle Science.
The recalled product
- Product
- Launch Sequence Euphoria Capsules, 10- count tins, ASIN B08ZJX4V9J, UPC Code 661020846864.
- Manufacturer
- Loud Muscle Science
- Category
- Drug — Unapproved Drug
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot# C07172101
- Exp date: 07/2024.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 6 recalled by Loud Muscle Science under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · Loud Muscle Science
See all →- SevereLaunch Sequence Aphrodisia Capsules recalled for undeclared tadalafil
FDA (Drugs) · 2022-07-27
- SevereDietary supplement found to contain undeclared pharmaceutical drug tadalafil
FDA (Drugs) · 2022-07-27
- SevereFDA Recalls Launch Sequence Euphoria Capsules for Undeclared Tadalafil
FDA (Drugs) · 2022-07-27
- HighDietary Supplement Marketed as Unapproved Drug Recalled by FDA
FDA (Drugs) · 2022-07-27
- HighLoud Muscle Science Recalls Unapproved Capsule Product Marketed as Aphrodisia
FDA (Drugs) · 2022-07-27
Same hazard · unapproved drug
See all →- CriticalBuy-Herbal Recalls Kian Pee Wan Capsules for Undeclared Drug Ingredients
FDA (Drugs) · 2026-08-19
- SevereMR. 7 Super capsules recalled as Class I over undeclared sildenafil
FDA (Drugs) · 2026-03-11
- SevereMojo Max Fusion capsules recalled as Class I over undeclared drug ingredients
FDA (Drugs) · 2026-03-11
- SevereSilintan herbal pills recalled as Class I for undeclared meloxicam
FDA (Drugs) · 2026-03-11
- SevereAgebox iKids-Growth Day Formula Capsules Recalled Over Undeclared Drug Ingredient
FDA (Drugs) · 2026-03-04